Prevalence of familial hypercholesterolemia and its association with coronary artery disease: A Chinese cohort study

Q1 Medicine
Xiapikatijiang Aihaiti, Shufeng Chen, Jianxin Li, Zhennan Lin, Qingmei Cui, Xue Xia, Fangchao Liu, Chong Shen, Dongsheng Hu, Keyong Huang, Yingxin Zhao, Fanghong Lu, Xiaoqing Liu, Jie Cao, Ling Yu, Ying Li, Huan Zhang, Zhenyan Fu, Liancheng Zhao, Jianfeng Huang, Dongfeng Gu, Xiangfeng Lu
{"title":"Prevalence of familial hypercholesterolemia and its association with coronary artery disease: A Chinese cohort study","authors":"Xiapikatijiang Aihaiti,&nbsp;Shufeng Chen,&nbsp;Jianxin Li,&nbsp;Zhennan Lin,&nbsp;Qingmei Cui,&nbsp;Xue Xia,&nbsp;Fangchao Liu,&nbsp;Chong Shen,&nbsp;Dongsheng Hu,&nbsp;Keyong Huang,&nbsp;Yingxin Zhao,&nbsp;Fanghong Lu,&nbsp;Xiaoqing Liu,&nbsp;Jie Cao,&nbsp;Ling Yu,&nbsp;Ying Li,&nbsp;Huan Zhang,&nbsp;Zhenyan Fu,&nbsp;Liancheng Zhao,&nbsp;Jianfeng Huang,&nbsp;Dongfeng Gu,&nbsp;Xiangfeng Lu","doi":"10.1002/cdt3.69","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Familial hypercholesterolemia (FH) is underrecognized, and its association with coronary artery disease (CAD) remains limited, especially in China. We aimed to investigate the prevalence of FH and its relationship with CAD in a large Chinese cohort.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>FH was defined using the Make Early Diagnosis to Prevent Early Death (MEDPED) criteria. The crude and age-sex standardized prevalence of FH were calculated based on surveys of the Prediction for Atherosclerotic Cardiovascular Disease Risk in China (China-PAR) project during 2007−2008. The associations of FH with incident CAD and its major subtypes were estimated with the cohort-stratified multivariate Cox proportional hazard models based on the data from the baseline to the last follow-up (2018−2020).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 98,885 included participants, 190 participants were defined as FH. Crude and age−sex standardized prevalence and 95% confidence interval (CI) of FH were 0.19% (0.17%–0.22%) and 0.13% (0.10%–0.16%), respectively. The prevalence varied across age groups and peaked in the group of 60–&lt;70 years (0.28%), and the peak prevalence (0.18%) in males was earlier, yet lower than the peak crude prevalence in females (0.41%). During a mean follow-up of 10.7 years, 2493 cases of incident CAD were identified. After multivariate adjustment, FH patients had a 2.03-fold greater risk of developing CAD compared to non-FH participants.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The prevalence of FH was estimated to be 0.19% in the participants, and it was associated with an elevated risk of incident CAD. Our study suggests that early screening of FH has certain public health significance for the prevention of CAD.</p>\n </section>\n </div>","PeriodicalId":32096,"journal":{"name":"Chronic Diseases and Translational Medicine","volume":"9 2","pages":"134-142"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/e5/CDT3-9-134.PMC10249193.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Diseases and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cdt3.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Familial hypercholesterolemia (FH) is underrecognized, and its association with coronary artery disease (CAD) remains limited, especially in China. We aimed to investigate the prevalence of FH and its relationship with CAD in a large Chinese cohort.

Methods

FH was defined using the Make Early Diagnosis to Prevent Early Death (MEDPED) criteria. The crude and age-sex standardized prevalence of FH were calculated based on surveys of the Prediction for Atherosclerotic Cardiovascular Disease Risk in China (China-PAR) project during 2007−2008. The associations of FH with incident CAD and its major subtypes were estimated with the cohort-stratified multivariate Cox proportional hazard models based on the data from the baseline to the last follow-up (2018−2020).

Results

Among 98,885 included participants, 190 participants were defined as FH. Crude and age−sex standardized prevalence and 95% confidence interval (CI) of FH were 0.19% (0.17%–0.22%) and 0.13% (0.10%–0.16%), respectively. The prevalence varied across age groups and peaked in the group of 60–<70 years (0.28%), and the peak prevalence (0.18%) in males was earlier, yet lower than the peak crude prevalence in females (0.41%). During a mean follow-up of 10.7 years, 2493 cases of incident CAD were identified. After multivariate adjustment, FH patients had a 2.03-fold greater risk of developing CAD compared to non-FH participants.

Conclusions

The prevalence of FH was estimated to be 0.19% in the participants, and it was associated with an elevated risk of incident CAD. Our study suggests that early screening of FH has certain public health significance for the prevention of CAD.

Abstract Image

家族性高胆固醇血症的患病率及其与冠状动脉疾病的关系:一项中国队列研究
家族性高胆固醇血症(FH)未被充分认识,其与冠状动脉疾病(CAD)的关联仍然有限,特别是在中国。我们的目的是在一个庞大的中国队列中调查FH的患病率及其与CAD的关系。方法采用早期诊断预防早期死亡(MEDPED)标准对FH进行定义。根据中国动脉粥样硬化性心血管疾病风险预测(China- par)项目2007 - 2008年的调查,计算了FH的粗患病率和年龄-性别标准化患病率。根据基线至最后一次随访(2018 - 2020)的数据,使用队列分层多变量Cox比例风险模型估计FH与冠心病及其主要亚型的关联。结果98,885名参与者中,190名参与者被定义为FH。FH的粗患病率和年龄-性别标准化患病率及95%可信区间(CI)分别为0.19%(0.17%-0.22%)和0.13%(0.10%-0.16%)。不同年龄组患病率差异较大,60 ~ 70岁年龄组患病率最高(0.28%),男性患病率最高(0.18%)较早,但低于女性粗患病率最高(0.41%)。在平均10.7年的随访中,发现2493例冠心病。多因素调整后,与非FH参与者相比,FH患者发生CAD的风险高出2.03倍。结论:FH患病率估计为0.19%,与冠心病发生风险升高有关。本研究提示FH的早期筛查对预防冠心病具有一定的公共卫生意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
195
审稿时长
35 weeks
期刊介绍: This journal aims to promote progress from basic research to clinical practice and to provide a forum for communication among basic, translational, and clinical research practitioners and physicians from all relevant disciplines. Chronic diseases such as cardiovascular diseases, cancer, diabetes, stroke, chronic respiratory diseases (such as asthma and COPD), chronic kidney diseases, and related translational research. Topics of interest for Chronic Diseases and Translational Medicine include Research and commentary on models of chronic diseases with significant implications for disease diagnosis and treatment Investigative studies of human biology with an emphasis on disease Perspectives and reviews on research topics that discuss the implications of findings from the viewpoints of basic science and clinical practic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信